Thus, the reduced expression of Cmklr1 in patients with NAFLD may be explained by reduced adiponectin levels and it may not be causally involved in the development of NAFLD. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.